Bacteria-Elicited Specific Thrombosis Utilizing Acid-Induced Cytolysin A Expression to Enable Potent Tumor Therapy

Adv Sci (Weinh). 2022 May;9(15):e2105086. doi: 10.1002/advs.202105086. Epub 2022 Apr 11.

Abstract

Given the special microenvironment of solid tumors, live microorganisms have emerged as drug delivery vehicles and therapeutic agents. Here, an acid-induced therapeutic platform is constructed using attenuated Escherichia coli to express the cytolysin A protein. The bacteria can target and colonize tumor tissues without causing notable host toxicity. Bacterial infection can disrupt blood vessels and trigger thrombosis in tumor tissues, resulting in the cut-off of nutrient supply to tumor cells and the arrest of tumor growth. The expression of cytolysin A induced by the acidic tumor microenvironment further strengthens thrombosis and provides a complementary therapeutic option due to its pore-forming function. In a xenograft mouse tumor model, this strategy reduces tumor proliferation by 79% and significantly prevents tumor metastasis, thus paving a new avenue for bacteria-based tumor therapy.

Keywords: acid-induced; bacteria; nutrient interruption; thrombosis; tumor therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bacteria
  • Cytotoxins / metabolism
  • Cytotoxins / therapeutic use
  • Drug Delivery Systems / methods
  • Escherichia coli / metabolism
  • Humans
  • Mice
  • Neoplasms* / therapy
  • Thrombosis* / drug therapy
  • Tumor Microenvironment

Substances

  • Cytotoxins